CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Interleukin-6 is a major regulator of lipoprotein(a) in humans in vivo
DOI 10.1055/s-0033-1341926
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN Müller, K Neumann, DM Schulte, M Laudes
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Lipoprotein (a) [Lp(a)] consists of an atherogenic LDL particle and pro-thrombotic apolipoprotein (a) [apo(a)] and has been considered as an independent cardiovascular risk factor. Recently, we have shown that inhibition of IL-6-signalling in humans in vivo lowers Lp(a) serum concentrations. Since there is currently no pharmaceutical agent available to reduce high Lp(a) levels, inhibition of IL-6 by neutralizi…
Zitieren
Zitierempfehlung
N Müller, K Neumann, DM Schulte, M Laudes (2013) Interleukin-6 is a major regulator of lipoprotein(a) in humans in vivo. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0033-1341926
Mit CareLit weiterarbeiten